Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SZLS.TO
- Price
- 0.04
- Stock movement up
- +- (%)
- Company name
- StageZero Life Sciences Ltd
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 4.94M
- Ent value
- 16.24M
- Price/Sales
- 2.02
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -28.62%
- 5 year return
- -39.16%
- 10 year return
- -39.33%
Last updated: 2025-04-12
DIVIDENDS
SZLS.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.02 |
| Price to Book | - |
| EV to Sales | 6.63 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 123.55M |
| EPS (TTM) | -0.02 |
| FCF per share (TTM) | -0.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.45M |
| Gross profit (TTM) | 598.33K |
| Operating income (TTM) | -2.57M |
| Net income (TTM) | -2.26M |
| EPS (TTM) | -0.02 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 24.41% |
| Operating margin (TTM) | -104.96% |
| Profit margin (TTM) | -92.18% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 20.72K |
| Net receivables | 138.82K |
| Total current assets | 225.42K |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 358.32K |
| Total assets | 583.74K |
| Accounts payable | 3.88M |
| Short/Current long term debt | 2.08M |
| Total current liabilities | 9.96M |
| Total liabilities | 11.32M |
| Shareholder's equity | -10.74M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -100.99K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -100.99K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -387.03% |
| Return on Invested Capital | 25.66% |
| Cash Return on Invested Capital | 1.15% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.04 |
| Daily high | 0.04 |
| Daily low | 0.04 |
| Daily Volume | 0K |
| All-time high | 17.52 |
| 1y analyst estimate | 1.25 |
| Beta | 0.07 |
| EPS (TTM) | -0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 19 May 2025 |
Downside potential
Loading...
Downside potential data
| SZLS.TO | S&P500 | |
| Current price drop from All-time high | -99.77% | -14.41% |
| Highest price drop | -99.77% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -74.68% | -11.07% |
| Avg time to new high | 124 days | 12 days |
| Max time to new high | 4770 days | 1805 days |
COMPANY DETAILS
Marketcap
4.94M
Marketcap category
Small-cap
Description
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.
Employees
40
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
TORONTO, ON / ACCESSWIRE / July 9, 2024 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene exp...
July 9, 2024
TORONTO, ON / ACCESSWIRE / May 23, 2024 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cance...
May 23, 2024
TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for s...
May 17, 2024